News Daily News TLR Rates Rise Steadily After Left Main PCI, but Deaths Stay Stable Michael O'Riordan January 09, 2024
Presentation TCT 2023 TARGET Clinical Trial Program (Alcohol-Mediated Renal Denervation) Presenter: David Kandzari October 25, 2023
Presentation TCT 2023 SPYRAL Clinical Trial Program (Radio-Frequency Renal Denervation) Presenter: David Kandzari October 25, 2023
News Conference News TCT 2023 LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI L.A. McKeown October 25, 2023
Presentation TCT 2023 Securing Reimbursement: The Pathway to Financial Stability Presenter: David Kandzari October 24, 2023
News Conference News CRT 2023 Renal Denervation in Black Patients: SYMPLICITY HTN 3 Reassures at 36 Months Yael L. Maxwell February 28, 2023
News Conference News CRT 2023 ‘Beeting’ In-stent Restenosis? Dietary Nitrate May Improve Outcomes Yael L. Maxwell February 27, 2023
News Daily News Reduction in BP Drives Treatment Preference for Hypertensive Patients Michael O'Riordan December 20, 2022
News Conference News AHA 2022 SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint Todd Neale November 09, 2022
Presentation AHA 2022 Renal Denervation in the Presence of Anti-Hypertensive Medications: Six-Month Results from the Randomized, Blinded, Sham-Controlled SPYRAL HTN – ON MED Trial Presenter: David E. Kandzari November 07, 2022
Presentation TCT 2022 It’s Time We Had These Devices Approved and Reimbursed Presenter: David E. Kandzari September 18, 2022
Presentation TCT 2022 Update on the SPYRAL Clinical Trials Program (Radiofrequency Renal Denervation) Presenter: David Kandzari September 17, 2022
News Conference News EuroPCR 2022 Shorter DAPT Sufficient Even in Complex HBR Patients: MASTER DAPT Yael L. Maxwell May 17, 2022
News Conference News EuroPCR 2022 Registry Data Hint at MACE Benefit With Renal Denervation Michael O'Riordan May 17, 2022
Presentation Fellows 2022 Case and Technique Reviews: High-Risk PCI and Cardiogenic Shock – The Role of Hemodynamic Support Presenter: David Kandzari May 07, 2022
News Conference News BIOFLOW V: Orsiro Still Offers Some Benefits at 5 Years Caitlin E. Cox March 02, 2022
Presentation CTO 2022 Surgical Turndowns: What We Know and What We Don’t Presenter: David Kandzari February 25, 2022